Ovarian Cancer Human Ovary, Left Total RNA, Donor 2029 (CAT#: DBFF-0624-HY5414)

Datasheet

Overview

Ovarian cancer is a malignant tumor that occurs on the ovaries and is one of the most common gynecological tumors in women. The cause of its pathogenesis is not completely clear, but it is generally believed that it is related to genetic, endocrine, environmental and other factors. Ovarian Cancer Human Ovary, Left Total RNA, Donor 2029 is extracted from ovary, left tissue of a single ovarian cancer human donor using a classical guanidine isothiocyanate-phenol: chloroform extraction method. RNA goes through rigorous quality control procedures to ensure the highest quality possible.

Product Summary

Quantity:

* For Research Use Only. Not For Clinical Use.

Donor Information

Gender

Female

Age At Sampling

74 yrs

Race

White or Caucasian

Medical Diagnosis

Adenocarcinoma of ovary, serous

Product Description

Species

Human

Tissue Name

Ovary, Left

Sample Diagnosis Category

Ovarian Cancer

28S/18S Ratio

1.82

Size

5 µg

Shipping

Dry ice

Storage

Stored at -80°C without repeated freeze and thaws

Applications

Northern blotting, ribonuclease protection assay, polymerase chain reaction analysis, rapid amplification of cDNA end analysis, cDNA synthesis, RNA differential display, microRNA studies, and RNA library construction.

Product Properties

Normal Ratio

40%

Lesional Ratio

Tumor Ratio

40%

Hypocellular/Acellular Tumor Stroma Ratio

10%

Hypercellular Tumor Stroma Ratio

10%

Necrosis Ratio

H&E Staining Pathological Verification

Tumor stroma (cellular): desmoplastic reaction; Tumor stroma (hypo/acellular): fibrosis; Non tumor structures: 40% ovarian stroma, 60% hilar vessels

Histopathological Grade

FIGO G3: Poorly differentiated

Tumor Stage

IIIB

Primary Tumor (T)

T3b

Regional Lymph Node (N)

Distant Metastasis (M)

Technical Specifications

Quality Control

Tested by spectrophotometer and denatured agarose gel electrophoresis

For Research Use Only | Not For Clinical Use